Low-Dose High-Frequency Enzyme Replacement Therapy Prevents Fractures without Complete Suppression of Painful Bone Crises in Patients with Severe Juvenile Onset Type I Gaucher Disease

By Cohen I.J.   Katz K.   Kornreich L.   Horev G.   Frish A.   Beutler R.E.  

Blood Cells, Molecules, and Diseases, Vol. 24, Iss. 3, 1998-09 ,pp. : 296-302

Academic Press

Access to resources Recommend Favorite

Comparative Efficacy of Dose Regimens in Enzyme Replacement Therapy of Type I Gaucher Disease

By Altarescu G.   Schiffmann R.   Parker C.C.   Moore D.F.   Kreps C.   Brady R.O.   Barton N.W.  

Blood Cells, Molecules, and Diseases, Vol. 26, Iss. 4, 2000-08 ,pp. : 285-290

Academic Press

Access to resources Recommend Favorite

Early-Onset Severe Neurological Involvement and D409H Homozygosity in Gaucher Disease: Outcome of Enzyme Replacement Therapy

By Michelakakis H.   Skardoutsou A.   Mathioudakis J.   Moraitou M.   Dimitriou E.   Voudris C.   Karpathios T.  

Blood Cells, Molecules, and Diseases, Vol. 28, Iss. 1, 2002-01 ,pp. : 1-4

Academic Press

Access to resources Recommend Favorite

Correlation of Bone Marrow Response with Hematological, Biochemical, and Visceral Responses to Enzyme Replacement Therapy of Nonneuronopathic (Type 1) Gaucher Disease in 30 Adult Patients

By Poll L.W.   Koch J-A.   Willers R.   Aerts H.   Scherer A.   Häussinger D.   Mödder U.   vom Dahl S.  

Blood Cells, Molecules, and Diseases, Vol. 28, Iss. 2, 2002-02 ,pp. : 209-220

Academic Press

Access to resources Recommend Favorite

Commentary: Dosage–Response in the Treatment of Gaucher Disease by Enzyme Replacement Therapy

By Beutler E.  

Blood Cells, Molecules, and Diseases, Vol. 26, Iss. 4, 2000-08 ,pp. : 303-306

Academic Press

Access to resources Recommend Favorite